Development and application of acute exposure guideline levels (AEGLs) for chemical warfare nerve and sulfur mustard agents

Journal of Toxicology and Environmental Health. Part B, Critical Reviews
Annetta WatsonVeronique Hauschild

Abstract

Acute exposure guideline levels (AEGLs) have been developed for the chemical warfare agents GB, GA, GD, GF, VX, and sulfur mustard. These AEGLs were approved by the National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances after Federal Register publication and comment, and judged as scientifically valid by the National Research Council Committee on Toxicology Subcommittee on AEGLs. AEGLs represent general public exposure limits for durations ranging from 10 min to 8 h, and for three levels of severity (AEGL-1, AEGL-2, AEGL-3). Mild effects are possible at concentrations greater than AEGL-1, while life-threatening effects are expected at concentrations greater than AEGL-3. AEGLs can be applied to various civilian and national defense purposes, including evacuation and shelter-in-place protocols, reentry levels, protective clothing specifications, and analytical monitoring requirements. This report documents development and derivation of AEGL values for six key chemical warfare agents, and makes recommendations for their application to various potential exposure scenarios.

References

Jan 1, 1979·Toxicology and Applied Pharmacology·F H DuffyV M Sim
Feb 11, 1975·Journal of the National Cancer Institute·J E Norman
Apr 25, 1975·Deutsche medizinische Wochenschrift·A Weiss, B Weiss
Jun 1, 1992·Ecotoxicology and Environmental Safety·A P WatsonJ D Adams
May 1, 1992·Pharmacology, Biochemistry, and Behavior·S R BabuS M Somani
Jan 1, 1992·Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology·I KoplovitzJ R Stewart
Jul 1, 1992·Annals of Emergency Medicine·F R Sidell, J Borak
Apr 1, 1991·Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology·R C GuptaW D Dettbarn
Mar 20, 1991·JAMA : the Journal of the American Medical Association·G R Howe
Jan 1, 1990·Annual Review of Pharmacology and Toxicology·M B Abou-Donia, D M Lapadula
Jul 1, 1990·Pharmacology & Toxicology·S A NieminenP Ylitalo
Mar 1, 1989·Reviews of Infectious Diseases·P M MurphyK F Wagner
Jul 1, 1989·Mutation Research·I D AdlerF E Würgler
Aug 1, 1989·Regulatory Toxicology and Pharmacology : RTP·A P WatsonG D Griffin
Aug 4, 1989·JAMA : the Journal of the American Medical Association·S A Carnes, A P Watson
Aug 1, 1989·Clinical Otolaryngology and Allied Sciences·R C HerdmanA J Pinching
Sep 1, 1989·Pharmacology & Toxicology·M Jokanović
Feb 1, 1985·Physiology & Behavior·M Ukai, T Kameyama
Mar 26, 1987·The New England Journal of Medicine·N Senanayake, L Karalliedde
Dec 1, 1988·Japanese Journal of Cancer Research : Gann·J YanagidaM Yamakido
Oct 1, 1988·British Journal of Industrial Medicine·D F EastonR Doll
Jan 1, 1988·Journal of Toxicology and Environmental Health·B W WilsonJ C Dacre
Mar 1, 1986·American Industrial Hygiene Association Journal·J H Ruth
Jul 1, 1986·Annals of Clinical Biochemistry·N A Haboubi, D I Thurnham
Sep 30, 1985·Toxicology and Applied Pharmacology·P AasF Fonnum
Dec 1, 1985·Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology·K SchoeneH J Bruckert
Jun 1, 1968·Lancet·S WadaR W Miller
Aug 1, 1971·The Journal of Clinical Endocrinology and Metabolism·G S LeveyJ McCarthy
Nov 1, 1972·European Journal of Pharmacology·C P SiegersG Back
Jun 1, 1974·The Journal of Investigative Dermatology·D A WeigandJ R Gaylor
Feb 1, 1974·Toxicology and Applied Pharmacology·F R Sidell, W A Groff
May 1, 1971·Archives of Environmental Health·R P Bonderman, D P Bonderman

❮ Previous
Next ❯

Citations

Jun 6, 2009·Disaster Medicine and Public Health Preparedness·Silas W SmithLewis R Goldfrank
Jun 24, 2010·Inhalation Toxicology·Jeanclare SeagraveGary R Grotendorst
Jun 2, 2009·Toxicology·K KeheT Zilker
May 20, 2008·Toxicology and Applied Pharmacology·Eugenia Bloch-ShildermanBen Avi Weissman
Sep 3, 2008·Risk Analysis : an Official Publication of the Society for Risk Analysis·Jeffrey J WhickerTed B Doerr
May 19, 2017·Disaster Medicine and Public Health Preparedness·Matthew John WatermeyerAbdullah Ebrahim Laher
Oct 30, 2010·BMC Systems Biology·Andrea Y WeisseWilhelm Huisinga
Oct 22, 2015·Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·UNKNOWN Bekanntmachung des Umweltbundesamtes
Jun 30, 2009·Prehospital and Disaster Medicine·Monica Wattana, Tareg Bey
Dec 30, 2016·Archives of Toxicology·Fazlullah KhanMohammad Abdollahi
Jun 13, 2012·Biomedical Instrumentation & Technology·P Richard Warburton

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.